Chemclin Diagnostics Co., Ltd. (SHA:688468)
China
· Delayed Price · Currency is CNY 7.67
+0.21 (2.82%)
Mar 10, 2026, 11:29 AM CST
Chemclin Diagnostics Revenue
Chemclin Diagnostics had revenue of 96.21M CNY in the quarter ending September 30, 2025, a decrease of -18.61%. This brings the company's revenue in the last twelve months to 353.32M, down -20.40% year-over-year. In the year 2024, Chemclin Diagnostics had annual revenue of 436.29M, down -2.03%.
Revenue (ttm)
353.32M
Revenue Growth
-20.40%
P/S Ratio
8.33
Revenue / Employee
561.72K
Employees
606
Market Cap
2.94B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medicalsystem Biotechnology | 1.47B |
| Guangdong Hybribio Biotech | 691.16M |
| Berry Genomics Co.,Ltd | 941.16M |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Shanghai Rendu Biotechnology | 162.06M |
| Thalys Medical Technology Group | 1.25B |
| SMO ClinPlus CO.,LTD. | 819.09M |
| Cowealth Medical China | 777.03M |